15.45MMarket Cap-0.11P/E (TTM)
5.3400High4.2701Low355.93KVolume4.3100Open4.3100Pre Close1.72MTurnover11.11%Turnover RatioLossP/E (Static)3.21MShares58.320052wk High1.28P/B15.41MFloat Cap1.800152wk Low--Dividend TTM3.20MShs Float1236.0000Historical High--Div YieldTTM24.82%Amplitude1.8000Historical Low4.8280Avg Price1Lot Size
Cingulate Stock Forum
📊⚡️📊
📊⚡️📊
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Positive
Working capital increased by $19.5M from December 2023
Raised $12.5M in capital during Q3 2024
Net loss decreased by 46% YoY to $3.2M
R&D expenses reduced by $2.5M YoY
Secured European patents for CTx-1301 in up to 30 territories
Regained Nasdaq compliance with $1.00 minimum bid requirement
Negative
Accumulated deficit increa...
via @Lnova 👌
No comment yet